Becton, Dickinson and Company Stock Quote & Summary Data
Dynamic quotes: Off
|
ETFs with BDX as a Top 10 Holding*Sponsored by:
| Weighting | ETF Name (Symbol) | 100-Day Price Change (%) |
|---|---|---|
| 2.59% | PowerShares Dynamic Heathcare (PTH) | +7.28 (21.78%) |
| 2.53% | iShares KLD Select Social Index Fund (KLD) | +2.71 (4.62%) |
| 2.53% | SPDR S&P Health Care Equipment (XHE) | +7.37 (13.01%) |
| 1.31% | First Trust Value Line Equity Allocation Index(sm)Fund (FVI) | +3.34 (17.04%) |
| 0% | Schwab US Dividend Equity ETF (SCHD) | +5.48 (19.26%) |
|
||
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Becton, Dickinson and Company (also known as “BD”) was incorporated under the laws of the State of New Jersey in November 1906, as successor to a New York business started in 1897. BD’s executive offices are located at 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880, and its telephone number is (201) 847-6800. All references in this Form 10-K to “BD” refer to Becton, Dickinson and Company and its domestic and foreign subsidiaries, unless otherwise indicated by the context. BD is a global medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. Business Segments BD’s operations consist of three worldwide business segments: BD Medical, BD Diagnostics and BD Biosciences. ... More ...
Consensus Recommendation |
|
Analyst Info |
|
| Annual EPS Est: | $5.37 |
| Quarterly EPS Est: | 1.48 |
| PEG Ratio: | 2.26 |
|
Mean Recommendation: View Summary / View All |
3.06 |
Data is provided by Zacks Investment Research